High dose temozolomide thiotepa and carboplatin with autologous stem cell rescue (ASCR) followed by continuation therapy with 13-cis-retinoic acid in patients with recurrent/refractory malignant brain tumors
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to find out what effects (good and/or bad) treatment with high dose temozolomide, thiotepa and carboplatin with a stem cell rescue followed by 13-cisretinoic acid has on children and adolescents with recurrent/refractory brain
Description
The purpose of this study is to find out what effects (good and/or bad) treatment with high dose temozolomide, thiotepa and carboplatin with a stem cell rescue followed by 13-cisretinoic acid has on children and adolescents with recurrent/refractory brain
Details
| Condition | recurrent/refractory malignant brain tumors |
|---|---|
| Age | 1years - 21years |
| Clinical Study Identifier | TX1420 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.